Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wankai New Materials is a leading Chinese manufacturer specializing in the production of polyethylene terephthalate (PET) resins. While primarily known for food and beverage packaging, the company produces specialized medical-grade PET used in healthcare applications such as medical device packaging, pharmaceutical bottles, and diagnostic labware. Wankai operates large-scale manufacturing facilities and is one of the largest PET producers globally by capacity. The company is publicly traded on the Shenzhen Stock Exchange and focuses on high-performance polymer research to meet stringent safety and quality standards for the healthcare and consumer sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wankai.